Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elizabeth C Wright

Showing results (61-70 of 78) with videos related to

Pageof 8
Sort By:
Hepatology (Baltimore, Md.)|April 12, 2011
Excess mortality in patients with advanced chronic hepatitis C treated with long-term peginterferonAdrian M Di Bisceglie, Anne M Stoddard, Jules L Dienstag, et al.
Controlled Clinical Trials|October 7, 2004
Evolution of the HALT-C Trial: pegylated interferon as maintenance therapy for chronic hepatitis C in previous interferon nonrespondersWilliam M Lee, Jules L Dienstag, Karen L Lindsay, et al.
Hepatology (Baltimore, Md.)|February 24, 2005
Associations among clinical, immunological, and viral quasispecies measurements in advanced chronic hepatitis CAlan Lee Rothman, Chihiro Morishima, Herbert L Bonkovsky, et al.
Hepatology (Baltimore, Md.)|October 14, 2009
Fibrosis progression in chronic hepatitis C: morphometric image analysis in the HALT-C trialZachary D Goodman, Anne M Stoddard, Herbert L Bonkovsky, et al.
Gastroenterology|December 7, 2010
Maintenance peginterferon therapy and other factors associated with hepatocellular carcinoma in patients with advanced hepatitis CAnna S Lok, James E Everhart, Elizabeth C Wright, et al.
The New England Journal of Medicine|December 5, 2008
Prolonged therapy of advanced chronic hepatitis C with low-dose peginterferonAdrian M Di Bisceglie, Mitchell L Shiffman, Gregory T Everson, et al.
Gastroenterology|September 22, 2009
Predicting clinical and histologic outcomes based on standard laboratory tests in advanced chronic hepatitis CMarc G Ghany, Anna S F Lok, James E Everhart, et al.
Gastroenterology|April 2, 2004
Peginterferon alfa-2a and ribavirin in patients with chronic hepatitis C who have failed prior treatmentMitchell L Shiffman, Adrian M Di Bisceglie, Karen L Lindsay, et al.
Clinical Trials (London, England)|November 6, 2009
Automated summaries of serious adverse events in the hepatitis C antiviral long-term treatment against cirrhosis trialMargaret C Bell, Patricia R Robuck, Elizabeth C Wright, et al.
Hepatology (Baltimore, Md.)|July 28, 2006
HCV RNA detection by TMA during the hepatitis C antiviral long-term treatment against cirrhosis (Halt-C) trialChihiro Morishima, Timothy R Morgan, James E Everhart, et al.
Pageof 8

Showing results (61-70 of 78) with videos related to

Sort By:
Pageof 8
Hepatology (Baltimore, Md.)|April 12, 2011
Excess mortality in patients with advanced chronic hepatitis C treated with long-term peginterferonAdrian M Di Bisceglie, Anne M Stoddard, Jules L Dienstag, et al.
Controlled Clinical Trials|October 7, 2004
Evolution of the HALT-C Trial: pegylated interferon as maintenance therapy for chronic hepatitis C in previous interferon nonrespondersWilliam M Lee, Jules L Dienstag, Karen L Lindsay, et al.
Hepatology (Baltimore, Md.)|February 24, 2005
Associations among clinical, immunological, and viral quasispecies measurements in advanced chronic hepatitis CAlan Lee Rothman, Chihiro Morishima, Herbert L Bonkovsky, et al.
Hepatology (Baltimore, Md.)|October 14, 2009
Fibrosis progression in chronic hepatitis C: morphometric image analysis in the HALT-C trialZachary D Goodman, Anne M Stoddard, Herbert L Bonkovsky, et al.
Gastroenterology|December 7, 2010
Maintenance peginterferon therapy and other factors associated with hepatocellular carcinoma in patients with advanced hepatitis CAnna S Lok, James E Everhart, Elizabeth C Wright, et al.
The New England Journal of Medicine|December 5, 2008
Prolonged therapy of advanced chronic hepatitis C with low-dose peginterferonAdrian M Di Bisceglie, Mitchell L Shiffman, Gregory T Everson, et al.
Gastroenterology|September 22, 2009
Predicting clinical and histologic outcomes based on standard laboratory tests in advanced chronic hepatitis CMarc G Ghany, Anna S F Lok, James E Everhart, et al.
Gastroenterology|April 2, 2004
Peginterferon alfa-2a and ribavirin in patients with chronic hepatitis C who have failed prior treatmentMitchell L Shiffman, Adrian M Di Bisceglie, Karen L Lindsay, et al.
Clinical Trials (London, England)|November 6, 2009
Automated summaries of serious adverse events in the hepatitis C antiviral long-term treatment against cirrhosis trialMargaret C Bell, Patricia R Robuck, Elizabeth C Wright, et al.
Hepatology (Baltimore, Md.)|July 28, 2006
HCV RNA detection by TMA during the hepatitis C antiviral long-term treatment against cirrhosis (Halt-C) trialChihiro Morishima, Timothy R Morgan, James E Everhart, et al.
Pageof 8